[Elsevier] Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM)

tarekcnn Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-27 00:42
Reward10points

journalㄩClinical Lung Cancer

AuthorsㄩDiego Enrico; Juan Elias Gomez; Danilo Aguirre; Natalia Soledad Tissera; Florencia Tsou; Carmen Pupareli; Delfina Peralta Tanco; Federico Waisberg; Andr谷s Rodr赤guez; Manglio Rizzo; Nicol芍s Minatta; Picon Rafael; Luis Basbus; Lorena Lupinacci; Diego Kaen; Mauro Ramos; Virginia Bluthgen; Nicolas Castagneris; Mar赤a P赤a Coppola; Alejandra Scocimarro; Mar赤a Florencia Guerra; Aldo Perfetti; Patricio Levit; Marco Galvez-Nino; Luis Mas; Leonardo Rojas; Jairo Zuluaga; Mat赤as Chac車n; Luis Corrales; Suraj Samtani; Oscar Arrieta; Andr谷s Cardona; Jordi Remon; Claudio Mart赤n

Published dateㄩ2024-12-

DOIㄩ10.1016/j.cllc.2024.09.005

PDF linkㄩhttps://www.sciencedirect.com/sc ... 525730424002006/pdf

Article linkㄩhttps://doi.org/10.1016/j.cllc.2024.09.005

Article SourceㄩElsevier BV


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
warmonger Post time 1 hour(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list